Maravai Lifesciences Holdings Inc (MRVI)

NASDAQ
29.40
+0.99(+3.48%)
After Hours
29.53
+0.13(+0.44%)
- Real-time Data
  • Volume:
    892,204
  • Day's Range:
    27.63 - 29.42
  • 52 wk Range:
    23.16 - 63.55

MRVI Overview

Prev. Close
28.41
Day's Range
27.63-29.42
Revenue
895.32M
Open
28.27
52 wk Range
23.16-63.55
EPS
1.81
Volume
892,204
Market Cap
7.5B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,461,744
P/E Ratio
16.24
Beta
-
1-Year Change
-25.13%
Shares Outstanding
255,207,408
Next Earnings Date
Aug 09, 2022
What is your sentiment on Maravai Lifesciences?
or
Market is currently closed. Voting is open during market hours.

Maravai Lifesciences Holdings Inc Company Profile

Maravai Lifesciences Holdings Inc Company Profile

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell
  • What happens with this stock
    0
    • Only down
      0
      • $MRVI Maintains KeyBanc Overweight USD 39 » USD 46 Maintains Credit Suisse Outperform USD 34 » USD 42
        0
        • It's a rocket! Revenue of $98.4 million for the fourth quarter and $284.1 million for the full year of 2020, representing 173.5% and 98.5% increases, respectively, over the corresponding periods of 2019; Net income (loss) and Adjusted EBITDA was $78.8 million and $169.2 million, respectively, for the year ended December 31, 2020, compared to $(5.2) million and $62.0 million, respectively, for the prior year. Established 2021 revenue guidance of $580.0 million to $630.0 million, representing growth of 104.2% to 121.8%. https://finance.yahoo.com/news/maravai-lifesciences-reports-fourth-quarter-210500901.html
          0
          • Why does no one talk about this company? The company has more than 5 thousand clients, including 20 leading world biopharmaceutical companies (including those testing anti-Covid drugs). For 9M2020, revenues was at $186m vs $143m for the whole 2019 ($124m for 2018); Net profit for 9m2020 was at $64m vs net loss of $5m for the whole 2019 (-$17m for 2018). I suppose it should demonstrate great results for YE2020 on March 2 - demand for its products from pharmaceutical companies should be high. => Bullish
            0
            • Am I the only one who sees EUR/USD page instead of MRVI
              0
              • No. Same here.
                0
            • Why is this page always broken
              0
              • Maravai holds a number of patents and offers innovative products and services including CleanCap®, CleanAmp®, GMPLink™, Antibody Affinity Extraction™ (AAE™), EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV™, Sterling™, Glen Pak™, Glen Gel-Pak™, Poly-Pak™, VECTASTAIN® and VECTASHIELD®.
                2
                • mthfk...
                  0